VRCA Return on Tangible Equity | Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. (VRCA) Return on Tangible Equity

2026-06-30: Return Tang Equity -724.01%.
2026-03-31: Return Tang Equity -111.03%.
2025-12-31: Return Tang Equity -72.29%.
2025-09-30: Return Tang Equity 152.66%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-724.01%
2026-03-31	-111.03%
2025-12-31	-72.29%
2025-09-30	152.66%
2025-06-30	277.97%
2025-03-31	355.24%
2024-12-31	776.66%
2024-09-30	249.60%
2024-06-30	653.63%
2024-03-31	-5353.91%
2023-12-31	-338.99%
2023-09-30	-114.21%
2023-06-30	-42.29%
2023-03-31	-34.86%
2022-12-31	-61.17%
2022-09-30	-62.76%
2022-06-30	-251.07%
2022-03-31	-167.65%
2021-12-31	-107.59%
2021-09-30	-94.28%
2021-06-30	-69.36%
2021-03-31	-54.70%
2020-12-31	-129.43%
2020-09-30	-95.33%
2020-06-30	-68.01%
2020-03-31	-53.97%
2019-12-31	-43.39%
2019-09-30	-39.28%
2019-06-30	-36.39%
2019-03-31	-31.75%
2018-12-31	-23.09%
2018-09-30	-15.05%
2018-06-30	-9.80%
2018-03-31	65.53%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-72.29%
2024-12-31	776.66%
2023-12-31	-338.99%
2022-12-31	-61.17%
2021-12-31	-107.59%
2020-12-31	-129.43%
2019-12-31	-43.39%
2018-12-31	-23.09%
2017-12-31	63.33%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
Valion Bio, Inc. (VBIO)	United States	$0.077B
Adicet Bio, Inc. (ACET)	United States	$0.078B	-0.81
Lifevantage Corp (LFVN)	United States	$0.078B	15.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40